CPHI vs FOXA · rev $4.1M vs P/E 14, $24.50B cap
China Pharma Holdings Inc (CPHI) versus Fox Corp Class A (FOXA) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Fox Corp Class A (FOXA) is a entertainment company listed on US.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
FOXA does not have a complete income-statement cache yet.
CPHI currently screens at market cap $29.0M. FOXA currently screens at market cap $24.50B and trailing P/E 14.1.
Not investment advice. Open the CPHI and FOXA stock pages for the full models.
Not investment advice.